BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Health Research Institute Research Talk - Richard Neubig\, M.D
 .\, Ph.D.
X-WR-TIMEZONE:Eastern Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20261008T155231Z
UID:tag:localist.com\,2008:EventInstance_37836894135364
DTSTART:20210922T140000Z
DTEND:20210922T150000Z
DESCRIPTION:“Academic Drug Discovery: Why do it?”\n\n\nAbstract: Most d
 rug discovery used to be done in large pharmaceutical companies. There was
  a focus on “proven” drug targets and multiple companies would be chas
 ing a small number of targets considered to be “low-hanging fruit”. In
  about 2007\, the NIH launched the Molecular Libraries Screening Network a
 nd many academic institutions took on the challenge of developing chemical
  probes for more challenging targets like protein-protein interactions\, m
 odulation of gene transcription\, etc. I will describe my lab’s journey 
 into academic drug discovery and a Ph.D. student’s high-throughput scree
 ning project that has driven much work in my lab for the last 15-18 years.
 \n\n \n\nDr. Neubig received his B.S. in chemistry from the University of 
 Michigan\, M.D. from Harvard Medical School in the Harvard-MIT Program in 
 Health Sciences and Technology\, and Ph.D. in pharmacology from Harvard Un
 iversity. He trained in internal medicine at the University of Michigan Ho
 spitals then joined the faculty in the departments of Pharmacology and Int
 ernal Medicine. He became Chair of Pharmacology & Toxicology at Michigan S
 tate University in 2013. He has studied GPCR signaling for most of his car
 eer and currently explores G proteins in genetic epilepsies. Since 2000\, 
 he has explored academic drug discovery\, particularly related to cancer\,
  scleroderma\, and other fibrotic diseases and he is the co-founder of a s
 tart-up FibrosIX Inc. He was the founding chair of the American Society of
  Pharmacology and Experimental Therapeutics (ASPET) Division of Molecular 
 Pharmacology and President of ASPET in 2013-2014. He received both the Ast
 ellas and ASPET-Pharmacia awards for translational pharmacology. He has be
 en active in international pharmacology serving on the IUPHAR Receptor Nom
 enclature Committee from 2000-2015 for which he was GPCR co-chair. He is a
  Fellow of ASPET and a Fellow of the American Association for the Advancem
 ent of Science (AAAS) and is past chair of Section S\, Pharmaceutical Scie
 nces of AAAS.
LOCATION:
SUMMARY:Health Research Institute Research Talk - Richard Neubig\, M.D.\, P
 h.D.
URL;VALUE=URI:https://events.mtu.edu/event/health_research_institute_resear
 ch_talk_-_richard_neubig_md_phd
CATEGORIES:Academics
CATEGORIES:Lectures/Seminars
END:VEVENT
END:VCALENDAR